(NASDAQ: STIM) Neuronetics's forecast annual revenue growth rate of 8.4% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.3%.
Neuronetics's revenue in 2026 is $155,096,000.On average, 6 Wall Street analysts forecast STIM's revenue for 2026 to be $12,523,013,436, with the lowest STIM revenue forecast at $11,932,484,965, and the highest STIM revenue forecast at $13,041,154,545. On average, 6 Wall Street analysts forecast STIM's revenue for 2027 to be $13,770,361,960, with the lowest STIM revenue forecast at $12,851,423,463, and the highest STIM revenue forecast at $14,561,289,124.
In 2028, STIM is forecast to generate $15,066,476,706 in revenue, with the lowest revenue forecast at $14,180,303,014 and the highest revenue forecast at $15,825,401,037.